Alterity Therapeutics Limited
Other OTCTotal Valuation
Alterity Therapeutics Limited carries a market capitalization of 108.75M, placing it among publicly traded companies globally. Its enterprise value stands at -40.50M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 108.75M |
| Enterprise Value | -40.50M |
Share Statistics
Alterity Therapeutics Limited currently has 182.55M shares outstanding.
| Shares Outstanding | 182.55M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Alterity Therapeutics Limited maintains a current ratio of 12.98, meaning it holds 13.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 12.98 |
| Quick Ratio | 12.62 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Stock Price Statistics
Alterity Therapeutics Limited's stock has gained approximately 233.33333% over the past 52 weeks. The 50-day moving average sits at 0.05, while the 200-day moving average is 0.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | 233.33333% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.02 |
| Average Volume (20 Days) | N/A |
Balance Sheet
Alterity Therapeutics Limited holds 40.66M in cash and equivalents against 155,457.00 in total debt, resulting in a net debt position of -33.16M. Total book value stands at 37.06M, with working capital of 42.34M providing operational flexibility.
| Cash & Cash Equivalents | 40.66M |
| Total Debt | 155,457.00 |
| Net Debt | -33.16M |
| Equity (Book Value) | 37.06M |
| Book Value Per Share | N/A |
| Working Capital | 42.34M |
Stock Splits
Alterity Therapeutics Limited's most recent stock split took place on June 3, 2026 with a 50:1 split ratio.
| Last Split Date | 6/3/2026 |
| Split Ratio | 50:1 |
Scores
Alterity Therapeutics Limited posts an Altman Z-Score of -5.77, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -5.77 |